
Loading, please wait...

Loading, please wait...

Ensuring ophthalmic hydrogel crosslinking safety is a vital step toward creating reliable alternatives to human donor corneas. Currently, the global shortage of donor tissue significantly restricts corneal transplantation procedures. While one donor cornea can occasionally assist two recipients, the supply still fails to meet growing clinical demand. Furthermore, natural grafts carry inherent risks of infection and cellular rejection. Therefore, researchers are exploring acellular synthetic materials produced through extrusion bioprinting. These innovative materials rely on photocrosslinking to achieve the mechanical stability required for ocular use.
A recent breakthrough identifies a reliable method to monitor the photoinitiator Lithium Phenyl (2,4,6-Trimethylbenzoyl) Phosphinate (LAP). Although LAP is common in bioprinting, residual non-radicalized molecules can be cytotoxic to ocular cells. Scientists have now demonstrated that spectrophotometry can detect these residuals at a specific wavelength of 372 nm. This measurement depends directly on the LAP concentration within the hydrogel. Thus, it provides a simple way to evaluate crosslinked materials and prevent potential side effects. By correcting these formulations before implantation, clinicians can ensure better outcomes for patients receiving synthetic grafts.
This detection method simplifies the verification of synthetic graft safety. It ensures that the crosslinking process is complete and the final material is biocompatible. For medical practitioners in India, where the burden of corneal disease is high, such innovations represent a significant step toward lab-grown solutions. Monitoring chemical residuals effectively reduces the risk of inflammation and graft failure. Consequently, this technique bridges the gap between bioengineering and safe clinical application.
LAP is a water-soluble photoinitiator used to harden hydrogels during the bioprinting of synthetic corneal grafts using light.
Residual or non-radicalized LAP can cause cytotoxic effects, potentially damaging the surrounding ocular tissue after transplantation.
It measures the absorbance of the material at 372 nm, where the non-radicalized LAP crosslinker has specific characteristics that correlate with its concentration.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or substitute for professional judgment. Refer to the latest local and national guidelines for clinical practice.
References

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


Researchers have developed a spectrophotometric method to detect residual LAP photoinitiators in synthetic corneal grafts, improving safety in ophthalmology...
4 months ago

A recent cross-sectional study of 15.2 million adults reveals a goiter prevalence of 1.3-2.5%. This detailed analysis explores why women and older adults are at higher risk, the dominance of non-toxic multinodular subtypes, and the clinical implications for primary care and endocrinology.
Today

A deep dive into the National Family Health Survey (NFHS-6) data showing a sharp rise in surgical deliveries in Karnataka, the public-private healthcare divide, clinical risks of elective surgeries, and the urgent need for standardized medical guidelines to safeguard maternal and newborn health.
Yesterday

This case study examines a 56-year-old man who experienced sequential bilateral common carotid artery occlusion. Findings revealed protein C deficiency and a patent foramen ovale (PFO), suggesting paradoxical embolism as the primary cause. This highlights the need for thorough thrombophilia screening.
Today

Perilunate dislocations are challenging orthopedic emergencies. This article explores a novel 4-anchor suture tape internal bracing technique that eliminates the need for K-wire retention, facilitating earlier recovery and excellent long-term functional outcomes as demonstrated in a recent clinical case.
Today

An international panel of experts has officially recognized fatty pancreas disorder as a distinct disease in the Melbourne Consensus. Learn about its diagnostic criteria using MRI, its pathophysiological association with type 2 diabetes and cancer, and evidence-based lifestyle and pharmacological interventions.
Today